ATI Pharmacology Exam

Correct Answer: Lorazepam

Explanation:

Lorazepam is a benzodiazepine that exerts CNS depressant effects, including sedation, anxiolysis, and muscle relaxation. When combined with opioids, which also depress the central nervous system, the result can be dangerously additive. This combination increases the risk of life-threatening respiratory depression, extreme sedation, coma, and death. Because of these significant risks, current guidelines recommend avoiding concurrent use unless absolutely necessary and under strict medical supervision. Any prescription for lorazepam in a client already receiving opioids should be carefully reviewed and clarified with the prescriber.

Why other options are wrong:

Metoprolol

Metoprolol is a beta-blocker that lowers blood pressure and heart rate. While it does have cardiovascular effects, it is not a CNS depressant and does not increase the risk of respiratory depression when used with opioids. The primary concern when using metoprolol with opioids is additive bradycardia or hypotension, which can be managed with routine monitoring. This combination is common in clinical settings, especially in clients with cardiovascular conditions.

Ondansetron

Ondansetron is an antiemetic that blocks serotonin receptors and is often prescribed to manage nausea, including that induced by opioid use. It does not act on the central nervous system in a depressant manner and is considered safe to administer with opioids. In fact, ondansetron can improve the comfort of clients receiving opioids by countering opioid-related gastrointestinal side effects, such as nausea and vomiting.

Naloxone

Naloxone is an opioid antagonist used to reverse the effects of opioid overdose, especially respiratory depression. It is not harmful in the context of opioid therapy but rather serves as a critical safety measure. Prescribing naloxone alongside opioids is considered a best practice, especially for clients at risk of overdose. Its inclusion does not require clarification—it enhances patient safety by ensuring a rapid reversal option is available if opioid toxicity occurs.

Correct Answer:

I can develop lithium toxicity if I experience vomiting or diarrhea.

Explanation:

Vomiting and diarrhea can lead to dehydration and a reduction in sodium levels, both of which significantly increase the risk of lithium toxicity. Lithium is primarily excreted by the kidneys, and its clearance is closely linked to sodium levels in the body. If sodium levels drop due to dehydration or loss of fluids, the kidneys may compensate by retaining more lithium, which can elevate its serum concentration and result in toxicity. This makes it crucial for individuals taking lithium to stay hydrated and maintain stable sodium intake, especially during episodes of vomiting or diarrhea. Clients should promptly report these symptoms to their healthcare provider to prevent complications.

Why Other Options Are Wrong:

I should take naproxen if I have a headache because aspirin can cause lithium toxicity.

This is incorrect because naproxen, like other nonsteroidal anti-inflammatory drugs (NSAIDs), can actually increase lithium levels and increase the risk of toxicity. NSAIDs inhibit renal prostaglandins, which are involved in kidney function, and this can reduce lithium clearance. Therefore, naproxen should be avoided in favor of acetaminophen for pain relief unless otherwise directed by a healthcare provider. Aspirin is generally considered safer in combination with lithium, though caution is still necessary.

I can develop lithium toxicity if I eat foods with lots of sodium.

This is incorrect. High sodium intake generally lowers lithium levels in the blood because the kidneys will excrete more lithium to maintain sodium balance. The real concern lies with low sodium levels, which can cause the kidneys to retain more lithium, raising the risk of toxicity. Therefore, it is important to maintain a consistent sodium intake, avoiding both extreme reductions and excessive increases in sodium.

I might need to take a daily diuretic along with my lithium to prevent lithium toxicity.

This is incorrect. Diuretics, especially thiazide diuretics, can cause sodium depletion and dehydration, which can increase the risk of lithium toxicity by causing the kidneys to retain more lithium. Clients should not take diuretics with lithium unless prescribed and closely monitored by their healthcare provider. In fact, diuretics may exacerbate the risk of lithium toxicity rather than prevent it.

Correct Answer A. Decreased urine specific gravity

Explanation of Correct Answer:

A. Decreased urine specific gravity

Furosemide is a loop diuretic that works by promoting the excretion of excess fluids and electrolytes, primarily sodium and water. A therapeutic response to furosemide would be a decrease in urine specific gravity, indicating that the kidneys are producing more dilute urine as the body excretes excess fluid. This is a sign of effective diuresis and fluid balance.

Why the Other Options Are Incorrect:

B. Increased calcium level

This is incorrect because furosemide is more likely to cause a decrease in calcium levels (hypocalcemia) rather than an increase. Furosemide can lead to the excretion of calcium through the kidneys.

C. Increased serum sodium level

This is incorrect because furosemide promotes the excretion of sodium along with other electrolytes. A decrease in sodium levels (hyponatremia) is more likely to occur with diuretic use, especially if fluid loss is excessive.

D. Decreased liver enzymes

This is incorrect because liver enzyme levels are not directly impacted by furosemide. Decreased liver enzymes would indicate liver improvement or reduced liver damage, but this is not related to the therapeutic effect of furosemide, which focuses on fluid balance and diuresis

Correct Answer: Carry a medic alert ID card.

Explanation:

This is the correct answer. Warfarin is an oral anticoagulant that prevents blood clots but also carries a high risk for serious bleeding, especially in emergency situations. A medic alert ID card or bracelet is crucial because it informs healthcare providers about the client's warfarin use in case of an emergency, which can impact treatment decisions, surgeries, or trauma care. Emergency providers must be aware of the anticoagulant therapy to prevent bleeding complications or drug interactions. This safety measure ensures that the client receives proper and prompt care.

Why Other Options Are Wrong:

Take ibuprofen as needed for headache or other minor pains.

This is incorrect because ibuprofen, a nonsteroidal anti-inflammatory drug (NSAID), increases the risk of gastrointestinal bleeding, particularly when taken with warfarin. Both warfarin and NSAIDs affect platelet function and increase bleeding risk. Therefore, clients on warfarin should avoid NSAIDs and use acetaminophen for minor pain relief, unless otherwise directed by their healthcare provider.

Report to the laboratory weekly to have blood drawn for aPTT.

This is incorrect because the activated partial thromboplastin time (aPTT) is used to monitor heparin therapy, not warfarin. Warfarin therapy is monitored by the International Normalized Ratio (INR), which reflects how long it takes for the blood to clot. The INR is derived from Prothrombin Time (PT) and should be checked regularly to ensure the dose of warfarin is within the therapeutic range. Monitoring aPTT is not applicable to clients on warfarin.

Increase intake of dark green vegetables.

This is incorrect because dark green vegetables like spinach, kale, and broccoli are high in vitamin K, which can counteract the effects of warfarin. Warfarin works by inhibiting vitamin K-dependent clotting factors, and a sudden increase in vitamin K intake can reduce its effectiveness. Clients on warfarin should maintain a consistent intake of vitamin K in their diet, avoiding drastic changes, and consult their healthcare provider before making dietary adjustments.

Summary:

Clients taking warfarin should be instructed to carry a medic alert ID card, which alerts healthcare providers to their use of the medication in emergencies. They should avoid NSAIDs, monitor INR regularly (not aPTT), and maintain a consistent intake of vitamin K without increasing it significantly. This education helps prevent complications associated with warfarin therapy.

Correct Answer: Remove the patch prior to going to bed.

Explanation:

Removing the nitroglycerin transdermal patch before bedtime is necessary to prevent tolerance. Continuous exposure to nitrates can lead to diminished effectiveness, so a daily nitrate-free period of 10 to 12 hours is recommended. Typically, the patch is worn during waking hours when physical activity and stress may trigger angina. Removing it at night, when the heart’s oxygen demand is naturally lower, helps maintain drug efficacy and reduces the likelihood of tolerance.

Why other options are wrong:

Discontinue the patch if you experience a headache

Discontinue the patch if you experience a headache is incorrect because headaches are a common and expected side effect of nitroglycerin due to its vasodilating effects. These headaches are typically mild to moderate and often improve with continued use or can be managed with over-the-counter analgesics such as acetaminophen. Abruptly discontinuing the patch without consulting a healthcare provider could result in increased frequency or severity of angina attacks, which may pose serious health risks.

Apply a new patch if you have chest pain

Apply a new patch if you have chest pain is not recommended, as the patch is intended for long-term prevention, not for treating acute anginal episodes. The transdermal route delivers medication slowly over time and does not provide the rapid relief needed during an angina attack. For sudden chest pain, sublingual nitroglycerin or nitroglycerin spray is the appropriate treatment, as these forms work within minutes. Misusing the patch in this way can delay effective treatment and potentially worsen the client’s condition.

Cover the patch with dry gauze when taking a shower

Cover the patch with dry gauze when taking a shower is unnecessary and potentially harmful. Nitroglycerin patches are generally water-resistant and designed to remain adhered during normal bathing or showering. Covering the patch could trap heat or moisture, which might accelerate drug absorption or cause skin irritation. Additionally, it may interfere with the patch’s adhesion or effectiveness, making this practice both unnecessary and inadvisable.

Correct Answer:

Proteinuria

Explanation:

Gentamicin is an aminoglycoside antibiotic known for its potential to cause nephrotoxicity, which is damage to the kidneys. One of the earliest signs of kidney damage is proteinuria, the presence of protein in the urine. Other signs of nephrotoxicity include elevated BUN and creatinine levels, along with decreased urine output. Given the risk of kidney damage, renal function should be closely monitored during gentamicin therapy. Nephrotoxicity is more likely with prolonged use or in clients with pre-existing kidney conditions, making early detection through proteinuria vital.

Why Other Options Are Wrong:

Hypoglycemia

This is incorrect because hypoglycemia is not an adverse effect of gentamicin. Hypoglycemia is more commonly seen with drugs like insulin or sulfonylureas, or occasionally with other antibiotics like quinolones, but it is not a side effect associated with aminoglycosides like gentamicin.

Nasal congestion

This is incorrect because nasal congestion is not a side effect of gentamicin. It is more commonly linked to allergies or upper respiratory infections but is not related to aminoglycoside use.

Visual disturbances

This is incorrect because gentamicin does not typically cause visual disturbances. Visual issues are more often associated with drugs like digoxin or conditions like isoniazid toxicity, but they are not common with gentamicin.

Correct Answer: Urticaria (hives)

Explanation:

Urticaria (hives) is a hallmark symptom of an allergic reaction, often seen in response to penicillin G. This condition presents as raised, red, itchy welts on the skin and is typically the first sign of a hypersensitivity reaction. Because penicillin is a common allergen, it is critical to monitor for early signs like hives, which can progress to more severe reactions, including anaphylaxis. Recognizing and addressing urticaria early can prevent complications and facilitate timely intervention.

Why Other Options are Wrong:

Bradycardia

This is incorrect. Bradycardia (slow heart rate) is not typically associated with allergic reactions to penicillin. In fact, anaphylaxis commonly leads to tachycardia (fast heart rate) due to vasodilation and a drop in blood pressure. Bradycardia is not an expected response during an allergic reaction to penicillin.

Pallor

This is incorrect. While pallor (paleness) can occur during severe hypotension or shock, it is not an early or specific indicator of an allergic reaction to penicillin. Pallor can be caused by numerous conditions and does not have the specificity of skin reactions like hives, which are more directly linked to allergic responses.

Dyspepsia

This is incorrect. Dyspepsia, or indigestion, is a gastrointestinal symptom and is not associated with an allergic reaction to penicillin. It is more related to issues such as acid reflux or gastrointestinal disorders, not hypersensitivity reactions. Therefore, it is not considered a sign of an allergic response.

Summary:

Urticaria (hives) is a common and early sign of an allergic reaction to penicillin G and should be monitored closely. Recognizing this symptom early can help prevent progression to more severe reactions, such as anaphylaxis. Other symptoms listed, such as bradycardia, pallor, and dyspepsia, are not typical of a penicillin allergy.

Correct Answer:

Ambulate the client to a chair prior to administering the medication

Explanation:

Alendronate is a bisphosphonate used to treat conditions like Paget’s disease and osteoporosis. One of the major risks of taking alendronate is esophagitis or esophageal ulceration, especially if the client lies down shortly after taking the medication. To prevent this, the client must remain upright (sitting or standing) for at least 30 minutes after taking the medication. Therefore, the priority action is to ambulate the client to a chair or ensure they are upright to minimize the risk of serious complications like esophageal injury.

Why Other Options Are Incorrect:

Administer the medication to the client before breakfast in the morning

While this is true (alendronate should be taken first thing in the morning, on an empty stomach), ensuring the client is upright is the more immediate concern to prevent esophageal damage. This step comes second after ensuring the client is in an appropriate position.

Give the medication to the client with water rather than milk

This is also correct (alendronate should be taken with a full glass of water and not milk or other beverages that could interfere with absorption). However, positioning the client upright is the more urgent priority.

Teach the client how to take the medication at home

While patient education is important, ensuring the client's safety by preventing esophageal complications is the immediate priority when administering the medication. Education can be provided afterward.

Correct Answer:

Amantadine

Explanation:

Amantadine is the correct answer because it is an antiparkinsonian agent that is used to treat extrapyramidal symptoms (EPS), which can occur as a side effect of antipsychotic medications like chlorpromazine. Chlorpromazine is a first-generation (typical) antipsychotic that can cause Parkinsonism, a condition characterized by symptoms such as mask-like facial expressions, involuntary movements, tremors, and rigidity. Amantadine works by increasing dopamine availability in the brain, which helps alleviate these Parkinsonism symptoms caused by dopamine blockade from the antipsychotic. As a result, amantadine is commonly used to treat EPS, particularly the motor symptoms associated with antipsychotic medications.

Why Other Options Are Wrong:

Bupropion (atypical antidepressant)

Bupropion is an atypical antidepressant that acts by inhibiting the reuptake of norepinephrine and dopamine. It is not effective for treating EPS and does not address the motor symptoms caused by antipsychotic medications. Additionally, bupropion can lower the seizure threshold, which could worsen neurological symptoms in patients with EPS, making it unsuitable for this situation.

Phenelzine (MAOI)

Phenelzine is a monoamine oxidase inhibitor (MAOI) used to treat depression. It does not have any role in treating extrapyramidal symptoms caused by antipsychotic drugs. Furthermore, MAOIs have dietary and drug interaction risks that could complicate treatment and are not used to manage the motor side effects associated with antipsychotic medications.

Hydroxyzine (antihistamine)

Hydroxyzine is an antihistamine primarily used for anxiety, nausea, and allergic reactions. Although some antihistamines (like diphenhydramine) can help treat certain EPS symptoms, hydroxyzine is not indicated for managing parkinsonian symptoms or the involuntary movements caused by antipsychotic medications. It is not effective for the specific symptoms the client is experiencing.

Summary:

Amantadine is the appropriate treatment for extrapyramidal symptoms (EPS) caused by antipsychotic medications like chlorpromazine. It addresses the motor symptoms by increasing dopamine activity in the brain. The other options, such as bupropion, phenelzine, and hydroxyzine, are not effective for treating EPS and are not suitable choices in this scenario.